Skip to content
topbanner-landingpage-uscap2024

Meet us at USCAP 2024 in Baltimore, Maryland

We are thrilled to announce that we will be attending the upcoming USCAP annual conference taking place in Baltimore from March 23-28. Our team is excited to meet you and share all the exciting updates we have in store for you. Read on for more information about our activities at the conference. 

Discover our IVDR-cleared and fully automated next-generation PD-L1, NSCLC algorithm for IHC biomarker analysis 

Visit our booth to learn about our new next-generation PD-L1 algorithm that provides decision support for pathologists. The algorithm has been cleared under the European In-Vitro Diagnostic Regulations (IVDR) and is designed to be fully automated, enabling pathologists to become more productive without manual steps. With exceptional accuracy and consistency in biomarker scoring related to eligibility for immune checkpoint inhibitors, it integrates seamlessly with PACS/IMS systems used by pathology labs, ensuring optimal workflow efficiency.


"I did spend less time with scoring using the APP, especially because the APP was able to make a good distinction between tumor cells and inflammatory cells."
Tri Q. Nguyen
Tri Q. Nguyen, pathologist at UMC Utrecht
The APP has IVDR clearance in the EU and is sold as Research use only in the US.
How consistent is your IHC staining? Have you measured it? 

Trust your staining through AI driven quantification and monitoring. See how Qualitopix® allows you to measure the consistency of your staining to detect variations and helps you standardize the process.   

  The workflow is simple: 

  1.  You follow your standard procedures for IHC staining, using standardized cell lines as a control.
  2. Scan your slides.
  3. Upload the images to Qualitopix.
  4. AI will analyze the images and over time detect variations in intensity, alerting you when something is off.
  5. Your team will be able to react to potential drifts and take action before the pathologist receives the images for assessment.  

 Would a tool like this serve your lab? Visit the Visiopharm booth #300 at USCAP to see a demo.  

Discover our partnerships

NanoString

Want to improve your GeoMx IF analysis and save time on the ROI/AOI selection step? We've teamed up with NanoString to develop automated, AI-driven image analysis for region selection in GeoMx. Visit our booth or stop by the NanoString at booth #1731 from 13:30-14:00 PM each day for a preview. Don't miss out on this opportunity to improve your GeoMx workflow.

Standard BioTools

We've partnered up with Standard BioTools to deliver our AI-driven highplex analysis software for faster, more streamlined analyses as a part of all Hyperion Imaging Systems, providing out-of-the-box solutions to accelerate highplex IMC studies. 

Together, we deliver Phenoplex with Hyperion systems for a unified image analysis pipeline and are developing data analysis methods for the Maxpar IMC Cell Segmentation kit to simplify cell segmentation and better extract meaningful biological data. 

If you're looking for a faster and more streamlined analysis of data acquired through Hyperion, make sure to visit our booths #1224 and #612 to learn more.

Posters being presented at AACR

Title: TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV associated oral squamous cell carcinoma

Session Date and Time: Sunday Apr 16, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 619

Poster Board Number: 20

Poster Section: 21

Authors: Y. Shi et al. from Xi'an Jiaotong University, China,; with MD Anderson Cancer Center

Title: Multiplex immunofluorescence and image analysis to investigate the role of the immune contexture and fibroblast activation for tumor cell budding in colorectal cancer

Session Date and Time: Sunday Apr 16, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 1018

Poster Board Number: 28

Poster Section: 41

Authors: D. Zielinski et al. from Discovery Life Sciences

Title: Precision immuno-oncology (IO) ISH/IF multiplex panel: Spatial detection of cytokines and IO biomarkers

Session Date and Time: Monday Apr 17, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 2322

Poster Board Number: 3

Poster Section: 45

Authors: B. Dennison et al. from Lanterne Dx

Title: Multiplex proteomics profiling with the imaging mass cytometry (IMC) identifies immune cell phenotypes associated with high NOS2/COX2 expression in ER- negative and TNBC patients

Session Date and Time: Tuesday Apr 18, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 3588

Poster Board Number: 13

Poster Section: 3

Authors: M. Pore et al. from NCI Frederick, MD

Title: A comprehensive guided workflow for highplex imaging, tissue segmentation, and multiplex cellular phenotyping for tumor microenvironment analysis

Session Date and Time: Tuesday Apr 18, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 4625

Poster Board Number: 15

Poster Section: 4

Authors: B. O’Neill et al. from Visiopharm; with Standard Bio Tools

Say hello to our team at booth #300

Do you have questions about digital pathology? Visit our friendly team at booth #300 and get the answers you need. Our experts are available to provide you with the latest insights on digital pathology techniques and applications. Keep an eye out for the friendly faces – they're waiting to welcome you to our booth

Kyle R Kisiel, Vice President, New Business Sales

Kyle R. Kisiel

Vice President, New Business Sales
Jeni Caldara, Clinical Technical Sales Specialist

Jeni Caldara

Clinical Technical Sales Specialist
Rickard Lindelöf, SVP, Clinical Business Development

Rickard Lindelöf

SVP, Clinical Business Development
Amanda Lowe, Managing Director, Americas

Amanda Lowe

Managing Director, Americas

If you have a burning question you can't wait to ask at USCAP, don't hesitate to get in touch with our team here.

For more information about the conference itself, visit the USCAP event page.

Presentations

USCAP 2024 - Agilent Digital Pathology Seminar 

Ralf Huss

March 25 from 5:30 - 7 PM
Meeting Room: Seminar Room 5 
Speaker: Ralf Huss, MD, PhD, Professor and Managing Director at BIOM, Biotech Cluster Development GmbH 

"How an Open, Scalable Digital Pathology Solution Can Improve Diagnostic Quality and Efficiency in Pathology Practice"

Digital pathology is increasing laboratory efficiency, clinical utility and quality control which results in reduction of time to diagnosis and improvement of patient outcomes. Unlock the future of Digital Pathology with an open scalable End to End solution. The seminar will present examples of how new agnostic tools can be used with great impact in pathology labs.  

Session highlight: Automated and AI-assisted quality of immunohistochemistry (IHC) forecasts assay failure and delivers diagnostic confidence.

Food and drinks will be served during the seminar.

Short Course: Fully Digital Sign Out, Step by Step. A complete guide to the glassless and paperless Pathologists office of today.

March 25 from 10 - 11:30 AM
Speakers: Professor Zaibo Li, MD, PhD, MBA (left) and Dr. Giovanni Lujan, MD (right)
The Ohio State University Wexner Medical Center

Professor Zaibo Li, MD, PhD, MBA Dr. Giovanni Lujan, MD

In this course Dr. Li and Dr. Lujan will demonstrate and explain step by step a full digital workflow based on the experience of The Ohio State University, who have been fully digital for over 3 years.   

Learning Objectives: 
Upon completion of this educational activity, learners will be able to:          

  • Identify the components for a successful transition into a digital workflow. 
  • Summarize the steps and skills needed to sign out a case using different combinations of integration between laboratory information systems (LIS) and image management systems (IMS) and compare the level of efficacy, efficiency and organization between digital and analog workflow. 
  • Discuss how a digital workflow is a pre-requisite to utilize artificial intelligence tools for different tasks such as biomarker quantification, lymph node metastasis detection and cancerous lesion screening, etc. 

Read more

Short Course: Validating And Implementing Artificial Intelligence Algorithms For Routine Breast Pathology Practice With Case-Based And Data-Driven Discussion

March 27 from 3:30 - 5:00 PM
Speakers: Professor Zaibo Li, MD, PhD, MBA (left) and Anil V. Parwani, MD, PhD, MBA (right)
The Ohio State University Wexner Medical Center

Professor Zaibo Li, MD, PhD, MBA Anil V. Parwani

Learning Objectives: 

  • Discuss current AI applications in breast pathology.
  • Summarize our experience and data of validating/implementing AI algorithms for clinical breast pathology practice.
  • Identify pitfalls and challenges in implementing AI algorithms for clinical breast pathology practice.

 

Long course: Beyond the Microscope - Tips to Take Evaluation of Medical Liver Biopsies to the Next Level and Into the Future

Heather L Stevenson-Lerner

March 27 from 12:55 - 2:15 PM 
Speaker: Heather L. Stevenson-Lerner, MD, PhD, FACP
University of Texas Galveston 

Learning Objectives: 

  • Discover new tools that may add value to medical liver biopsy reports. 
  • Develop an appreciation for the heterogeneity of individual hepatic microenvironments, paving the way for precision medicine approaches. 
  • Learn steps to implement a Liver Diseases Diagnostic Management Team, where complex cases and results can be discussed with trainees and experts. 

Read more 

Posters being presented at USCAP

Evaluation of Cell Lines in Combination with Artificial Intelligence as Quality Tools to Monitor HER2 IHC Test Reproducibility

Session date and time: Tuesday, March 26

Authors: Birgit Truumees, Jeppe Thagaard, Stine Amtoft Nielsen, Mateusz Tylicki, Lise Emanuelsen, Søren Nielsen

Improving Bladder Cancer Grading with AI-Enabled Computer Vision: Externally Validating Grading Models and Incorporating Highly Prognostic Nuclear Features

Session date and time: Monday, March 25

Authors: Minqi Xu, MD; Katherine Lindale, MSc, Bsc; Ava Slotman; Raquel Benitez, PhD; Dan Winkowski, PhD; Robert J. Gooding, PhD; Amber Simpson, PhD; Nuria Malats, MD, PhD; David M. Berman, MD, PhD

A Comprehensive Comparative Assessment of PD-L1 Tumor Proportion Scores using Artificial Intelligence and Pathologists

Session date and time: Monday, March 25

Authors: Trevor Toussieng, DO; Mariza De Peralta-Venturina, MD; Raghavendra Pillappa, MBBS; Keluo Yao, MD

Pathological parameter for anti-PD-1 therapy response evaluation of melanoma in Asians

Session date and time: Tuesday, March 26

Authors: Tao Jiao, Qian Guo, Haizhen Du, Xia Liu, Hongzhe Sun, Shuo Han, Lin Zhu, Zhifu Zhang, Na Li, Yan Kong

Performance Evaluation of Artificial Intelligence in Automated Assessment of HER2 Immunohistochemistry in Breast Cancer

 

Session date and time: Wednesday, March 27

 

Authors: Si Wu, Xiang Li, Jiaxian Miao, Dongyi Xian, Willis Wei, Yueping Liu

 

Get your free #VisiopharmCartoons artwork at our booth

Use AI to help recognise cancer cells from digital pathology images.

Use AI to help recognise cancer cells from digital pathology images.

Get automated reporting to document staining consistency records to support documentation and audit preparation with Qualitopix™ from Visiopharm.

Get automated reporting to document staining consistency records to support documentation and audit preparation with Qualitopix™ from Visiopharm.